Channels

Papers
(The TQCC of Channels is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
An update on regulation of the polymodal TRPV4 channel by protein phosphorylation77
Cholesterol inhibits capsaicin activation of the TRPV1 channel50
Non-conducting functions of ion channels: The case of integrin-ion channel complexes46
Cycling matters: Sex hormone regulation of vascular potassium channels45
Graded activation of mutant K41C-KCNE1:KCNQ1 channel complexes by mefenamic acid38
Structural and functional mapping of ion access pathways in the human K + -dependent Na + /Ca 27
Orai store-operated Ca 2+ entry channels modulate urethral smooth muscle contractility25
Binding kinetics of quaternary ammonium ions in Kcv potassium channels23
A phenylalanine at the extracellular side of Kir1.1 facilitates potassium permeation22
Hippocampus-related cognitive disorders develop in the absence of epilepsy and ataxia in the heterozygous Cacna1a mutant mice tottering21
One pocket to activate them all (?): Efforts on understanding the modulator pocket in K2P channels21
Piezo1 channel: A global bibliometric analysis from 2010 to 202420
SLC26A9 in airways and intestine: secretion or absorption?20
The research progress into cellular mechanosensitive ion channels mediating cancer pain18
Piezo1-mediated fluid shear stress promotes OPG and inhibits RANKL via NOTCH3 in MLO-Y4 osteocytes17
Novel insights into voltage-gated ion channels: Translational breakthroughs in medical oncology17
Cardiac L-type calcium channel regulation by Leucine-Rich Repeat-Containing Protein 1015
Molecular mechanisms of function deficiencies in KCNQ1 variants associated with Jervell and Lange–Nielsen syndrome15
Sclareol and cinnarizine are non-selective inhibitors of voltage-gated Cav1.3 L-type Ca 2+ channels13
Transient receptor potential vanilloid type 1: cardioprotective effects in diabetic models13
Reducing agents facilitate membrane patch seal integrity and longevity12
SCN3A -related neurodevelopmental disorder: Clinical case reports and biophysical characterization12
Mechanism of carvedilol induced action potential and calcium alternans12
Structure of the voltage-gated potassium channel K V 1.3: Insights into the inactivated conformation and binding to therapeutic leads11
Structural biology of voltage-gated calcium channels11
Bladder under stress: Pathological and adaptive shifts in channel expression11
0.10811400413513